| Dr Nagavardhan Vasuki, MD | |
|
5401 S Congress Ave Ste 102, Atlantis, FL 33462-6636 | |
| (561) 967-5033 | |
| (561) 967-5424 |
| Full Name | Dr Nagavardhan Vasuki |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 19 Years |
| Location | 5401 S Congress Ave Ste 102, Atlantis, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790969137 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Atlantis, FL | Hospital |
| Palms West Hospital | Loxahatchee, FL | Hospital |
| Wellington Regional Medical Center Llc | Wellington, FL | Hospital |
| Hendry Regional Medical Center | Clewiston, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Specialists Of The Palm Beaches Inc | 0244143758 | 110 |
| Independent Ekg Consultant's, Inc. | 4981671740 | 8 |
News Archive
Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.
The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.
› Verified 9 days ago
| Entity Name | Medical Specialists Of The Palm Beaches Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386687580 PECOS PAC ID: 0244143758 Enrollment ID: O20031111000205 |
News Archive
Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.
The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.
› Verified 9 days ago
| Entity Name | Independent Ekg Consultant's, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689626756 PECOS PAC ID: 4981671740 Enrollment ID: O20040913000506 |
News Archive
Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.
The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.
› Verified 9 days ago
| Entity Name | Ecg Consultants Of Bethesda Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588811533 PECOS PAC ID: 8628134665 Enrollment ID: O20090227000151 |
News Archive
Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.
The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nagavardhan Vasuki, MD 7593 W Boynton Beach Blvd Ste 220, Boynton Beach, FL 33437-6162 Ph: (561) 966-7717 | Dr Nagavardhan Vasuki, MD 5401 S Congress Ave Ste 102, Atlantis, FL 33462-6636 Ph: (561) 967-5033 |
News Archive
Laboratory tests confirmed the presence of WNV antibodies in a 91-year-old San Fernando Valley resident who passed away late last week. This is the third reported death for WNV in California and the first for Los Angeles County.
The European Commission has awarded €1 million to fund a campaign promoting health ageing 'Sharing Age' coordinated by Dr Sabina Brennan of the Trinity College Institute of Neuroscience.
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.
Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.
› Verified 9 days ago
James Heron, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, #218, Atlantis, FL 33462 Phone: 561-968-0307 Fax: 561-968-7673 | |
Roberto Von Sohsten, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, #102, Atlantis, FL 33462 Phone: 561-967-5033 Fax: 561-967-8974 | |
Dr. Samantha Sylvonne Kerry-ann Nicholson-spence, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-548-1273 | |
Alexander Chernobelsky, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, #102, Atlantis, FL 33462 Phone: 561-967-5033 Fax: 561-967-8974 | |
Denzil S Seedial, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, Ste 204, Atlantis, FL 33462 Phone: 561-967-4118 Fax: 561-967-3463 | |
Dr. Daphnee Marie Hutchinson, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-548-1750 | |
Dr. Farahnaz Angella, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 180 Jfk Dr, Suite 311, Atlantis, FL 33462 Phone: 561-434-0353 Fax: 561-357-0869 |